Medtronic PLC/ IE00BTN1Y115 /
5/16/2024 7:57:09 AM | Chg. -0.0400 | Volume | Bid11:30:00 AM | Ask11:30:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
77.8900EUR | -0.05% | - Turnover: - |
77.8200Bid Size: 300 | 78.1300Ask Size: 300 | 103.36 bill.EUR | - | - |
GlobeNewswire
5/13
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
5/9
Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for im...
GlobeNewswire
4/30
Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Paten...
GlobeNewswire
4/23
Tactile Medical Announces CEO Transition and Preliminary First Quarter 2024 Revenue
GlobeNewswire
4/23
Blue Cross and Blue Shield of Minnesota Announces Chris Boles as Vice President of Medicare, Melissa...
GlobeNewswire
3/27
Increased Adoption of Artificial Intelligence Across the Healthcare Industry Driving Strong Market G...
GlobeNewswire
3/26
Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of D...
GlobeNewswire
3/13
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy ...
GlobeNewswire
3/6
Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemod...
GlobeNewswire
2/26
Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambu...
GlobeNewswire
2/5
Inspire Medical Systems, Inc. Announces Chair Marilyn Carlson Nelson to Retire and Timothy P. Herber...
GlobeNewswire
1/8
Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pace...
GlobeNewswire
12/29/2023
Visionary Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its ...
GlobeNewswire
11/13/2023
Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update